CIRM Names Interim President: Jonathan Thomas, Former Chair of the CIRM Governing Board for 11 Years
The board of the California stem cell agency appointed the former chairman of the board, Jonathan Thomas, this morning as the interim president of the $12 billion stem cell and gene therapy program.
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.